The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancer
- 1 February 1996
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 22 (1) , 74-77
- https://doi.org/10.1016/s0748-7983(96)91649-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancerBreast Cancer Research and Treatment, 1993
- Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasivenessBioEssays, 1993
- Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.Gut, 1993
- The role of proteolytic enzymes in cancer invasion and metastasisClinical & Experimental Metastasis, 1992
- Tumor‐cell dissociation at the invasion front: A new prognostic parameter in gastric cancer patientsInternational Journal of Cancer, 1992
- Plasminogen activators in human gastric cancers: Correlation with DNA ploidy and immunohistochemical stainingInternational Journal of Cancer, 1991
- Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogeneCell, 1990
- Morphological predictors of survival in advanced gastric carcinoma univariate and multivariate analysisZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958